Successfully reported this slideshow.
Your SlideShare is downloading. ×

OS16 - 3.1.d Genetic Characterization of FMD Viruses in Balochistan, Pakistan - S. M.Jamal

Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad

Check these out next

1 of 9 Ad
Advertisement

More Related Content

More from EuFMD (20)

Recently uploaded (20)

Advertisement

OS16 - 3.1.d Genetic Characterization of FMD Viruses in Balochistan, Pakistan - S. M.Jamal

  1. 1. Open Session of the EuFMD - Cascais –Portugal 26-28 October 2016 Syed M. Jamal Department of Biotechnology University of Malakand, Pakistan Genetic Characterization of foot-and-mouth disease viruses in Balochistan, Pakistan
  2. 2. OS16 FMD in Pakistan Endemic country Three serotypes (O, A, Asia-1) Multiple subtypes Studies on genetic diversity of FMDVs in Pakistan (Jamal et al 2011a,b,c; Waheed et al., 2012; Jamal et al., 2012; Brito et al., 2013) However, similar information on FMDV in Balochistan province of Pakistan is not available. Objectives of the study was to characterize FMDVs in Balochistan
  3. 3. OS16 o Southwestern part of the country o The largest province shares borders with Afghanistan (1100 km) and Iran (909 km) o The geographical location of this Province o Animal Trade among Pakistan, Iran and Afghanistan o spread of transboundary animal diseases including FMD Afghanistan Iran Arabian sea India Balochistan Province of Pakistan
  4. 4. OS16 Number of samples collected = 35 Epithelial tissues = 2 Oral swabs = 33 Number of locations = 8 Transported to ANSES, Laboratory for Animal Health, France Analysis of samples  Ag-ELISA  Cell culture (foetal goat tongue cell line, ZZ-R 127) & Ag-ELISA  Pan-FMDV 3D assay  Serotype-specific qRT-PCR assays  Sequencing Methodology
  5. 5. Results Assay Original samples Tissue culture Total Positive Total Positive Ag-ELISA 35 0 8 8 Pan-FMDV rRT- PCR 35 31 8 8 Serotype-specific rRT-PCR 35 29 8 8 A = 5 As = 2 A/As = 1 No sample positive for serotype O
  6. 6. OS16 FAR-11 BAL-11 HER-10 A-Iran05 HIR/AFG/L1575/2009 (HQ439291) PUN/PAK/L2808/2009 (HQ439257) TAK/AFG/L1420/2009 (HQ439264) PUN/PAK/L1354/2009 (HQ439251) PAN/AFG/L3641/2009 (HQ439309) HIR/AFG/L1571/2009 (HQ439289) A/BAL/PAK/ISO2/2011 (JX435106)* JAW/AFG/L1439/2009 (HQ439278) GU384686 (A/PAK/76/2009) SIN/PAK/L574/2009 (HQ439244) SIN/PAK/L578/2009 (HQ439245) HIR/AFG/L1486/2009 (HQ439283) SAR/AFG/L1435/2009 (HQ439274) FJ755009 (AFG/44/2007) FJ755007 (AFG/6/2007) AFG-07 SAR/AFG/L1434/2009 (HQ439273) KAB/AFG/L1163/2008 (HQ439262) SIN/PAK/L695/2009 (HQ439248) SIN/PAK/L693/2009 (HQ439246) FJ755010 (BAR/6/2008) FJ755011 (BAR/7/2008) A/BAL/PAK/23/2011 (KT832834) A/BAL/PAK/ISO3/2011 (JX435107) A/BAL/PAK/12/2011 (KT832827) A/BAL/PAK/ISO4/2011 (KT832825) A/BAL/PAK/30/2011 (KT832837) A/BAL/PAK/34a/2011 (KT832840)* A/BAL/PAK/19/2011 (KT832829) A/BAL/PAK/05/2011 (KT832824) A/BAL/PAK/21/2011 (KT832830)* A/BAL/PAK/ISO7/2011 (KT832835) A/BAL/PAK/ISO8/2011 (KT832836) A/BAL/PAK/ISO5/2011 (JX435108) A/Mainkum/02/2012 (JQ765588) A/Kirgizia/11/2011 (JQ765587) A/IRN/12/2012 (KT223558) A/BAL/PAK/ISO1/2011 (JX462599) A/BAL/PAK/22/2011 (KT832832)* A/BAL/PAK/30a/2011 (KT832838) A/BAL/PAK/34/2011 (KT832839)* BAD/AFG/L3025/2009 (HQ439306) BAD/AFG/L2815/2009 (HQ439297) PUN/PAK/L2809/2009 (HQ439258) PUN/PAK/L1364/2009 (HQ439253) EU414535 (Pak/9/2003) EU414534 (PAK/28/2002) FJ798194 (A/PAK/73/2007) AY593763 (A22/IRQ/64) 99 99 99 99 98 60 59 99 98 89 95 90 99 99 78 91 99 5394 88 99 81 82 99 62 65 0.02 ML tree generated using VP1 coding sequences of serotype A FMDV Pakistan & Afghanistan 2009 Afghanistan 2010 Kirgizstan 2011 Iran 2012 Kazakhstan 2012 New sublineage
  7. 7. OS16 As/BAM/AFG/L2824/2009 (HQ439204) As/BAM/AFG/L2823/2009 (HQ439203) As/BAM/AFG/L3/2009 (HQ439196) As/BAM/AFG/L1/2009 (HQ439194) As/BAM/AFG/L639/2009 (HQ439198) As/AFG/44/2003 (EF457992) As/KRG/1/2004 (FJ785248) As/HKN/1/2005 (DQ121114) As/TAJ/6/2004 (FJ785276) As/UZB/2003 (FJ785277) As/AFG/33/2003 (EF457990) As/AFG/26/2003 (EF457989) As/PAK/1/2004 (DQ121128) As/PAK/1/2004 (HQ268513) PAK/069/2003 (HQ268514) As/PAK/69/2003 (DQ121127) As/PAK/31/2002 (DQ121125) As/PAK/030/2002 (JF749849) As/PAK/30/2002 (DQ121124) Group-II As/PAK/20/2003 (DQ121126) As/PAK/3/98 (FJ785261) Group-VI As1/Shamir/ISR/89 As/IRN/25/2001 (FJ785244) As/AFG/4/2001 (DQ121110) As/AFG/1/2001 (DQ121109) Group-I As/SIN/PAK/L2810/2009 (HQ439189) As/SIN/PAK/L2812/2009 (JN006721) As/SIN/PAK/L2954/2009 (HQ439193) As/SIN/PAK/L5/2008 (HQ439187) As/Slemani/2/IRQ/2014 (KM047049) As/Slemani/IRQ/2012 (JX455113) As/TUR/13/2013 (KM268898) As/BAL/PAK/ISO2/2011 (JX435109)* As/BAL/PAK/08/2011 (KT832826) As/BAL/PAK/ISO6/2011 (KT832828) As/BAL/PAK/21/2011 (KT832831)* As/BAL/PAK/22/2011 (KT832833)* As/BAL/PAK/34/2011 (KT832841)* As/BAL/PAK/ISO1/2011 (JX435110) Group-VII (Sindh-08) 98 99 98 81 94 97 100 88 73 98 99 86 100 99 97 89 78 85 94 90 ML tree generated using VP1 coding sequences of serotype Asia-1 FMDV
  8. 8. OS16 Conclusions o Different sublineages within A-Iran05 are in circulation and new sublineages arise with time. o Detection of new strain of serotype A suggests that continuous surveillance of the disease is necessary o Oral swab samples can be used for virus isolation and subsequent characterization o Collection of oral swab samples is non invasive compared to the epithelial samples and therefore acceptable to the animal owners o Detection of two different serotypes or/and two different strains of the same serotype in one animal/sample shows complexity of the disease in the region.
  9. 9. OS16 Acknowledgements Asad Ulllah, CASVAB, University of Balochistan Stephan Zientara and Labib Kassimi and their team EuFMD team Higher Education Commission, Islamabad, Pakistan GFRA

×